In addition, survival analysis based on ExSurv database revealed that breast cancer patients with high expression of Fbxo22 had a higher survival rate (hazard ratio = 1.557, p-value = 0.024) (Fig. 1D, Tables S2, S3). Here, FBXO22 is linked to breast carcinoma.